Introduction This subanalysis aimed to provide real-world data on venous thromboembolism
(VTE) from patients with lung cancer in the Cancer-VTE Registry. Methods The primary …

Cancer patients, especially those with lung cancer and undergoing chemotherapy, have an
elevated risk for venous thromboembolism (VTE). This study assessed incidence, timing …

Background Patients with lung cancer are known to be at increased risk for venous
thromboembolism (VTE). Venous thromboembolism is associated with increased risk for …

Background Venous thromboembolism (VTE) is highly prevalent in cancer patients and can
cause severe morbidity. VTE treatment is essential, but anticoagulation increases the risk of …

Background: The incidence of venous thromboembolism (VTE) by lung cancer histology and
stage is unknown. Objectives: To determine the incidence of VTE and the risk factors …

Management of cancer-associated venous thromboembolism (VTE) is essential in treatment
selection and cancer prognosis. However, to date, there is no method to assess the risk of …

Background: Venous thromboembolism (VTE) is a potentially preventable cause of death in
people with lung cancer. Identification of those most at risk and high-risk periods may …

Epidemiology and risk factors for venous thromboembolism in... : Current Opinion in Oncology
Epidemiology and risk factors for venous thromboembolism in lung cancer : Current Opinion …

Background The natural history of patients with lung cancer and venous thromboembolism
(VTE) has not been consistently evaluated. Methods We used the RIETE (Registro …

Venous thromboembolism (VTE) is frequently observed in patients with advanced cancer.
The objective of this prospective observational study was to estimate, based on intensive …